Prof. Dr.

Christa Elisabeth Müller

Head of Pharmaceutical Chemistry I, Pharmaceutical Institute

Biographical data
Born on April 4, 1960 in Rottweil, Baden-Württemberg, Germany
School
1967 - 1970 Elementary school in Zimmern-Stetten near Rottweil
1970 - 1979 Droste-Hülshoff-Gymnasium Rottweil (general high school degree)
University
1979 Enrolment at the Eberhard-Karls-University Tübingen, Germany
1979 - 1980 Studies in Rhetorics, Education and Ethnology
1980 - 1983 Studies in Pharmacy
Academic Degrees
1988 Ph.D. (Dr. rer. nat.), University of Tübingen
Dissertation: (“Synthesis and properties of chiral amphiphilic compounds
and liposomal prodrugs with unsymmetrically substituted disulfide bridge”)
supervised by Prof. Dr. H. J. Roth, Pharmaceutical Chemistry
1994 Habilitation in Pharmaceutical Chemistry with a postdoctoral thesis entitled
(“Adenosine receptor antagonists: synthesis, in-vitro testing, structure-activity
relationships”)
Professional Career
1983/84 Practical term at a public pharmacy in Stuttgart
1985 German licensure as a pharmacist
1989/90 and 1992 Exchange scientist at the Laboratory of Bioorganic Chemistry,
National Institutes of Health, Bethesda, Maryland, USA,
with Dr. John W. Daly
1994-1998 University Professor (C3) for Pharmaceutical Chemistry at the University of
Würzburg, Bavaria, Germany
since 1998 University Professor (C4) for Pharmaceutical Chemistry at the University of
Bonn, North-Rhine-Westfalia, Germany
2000.2001 Acting Director of the Pharmaceutical Institute
since 2001 Vice-speaker of the DFG-funded research training group GRK677
since 2002 Vice-speaker of the DFG-funded research training group GRK804
2001-2004 Vice-rector for planning and finances at the University of Bonn
2007 Co-founder in charge (together with A. Pfeifer) and vice-speaker of the
PharmaCenter Bonn (PZB)
since 2008 Vice-speaker of the NRW international graduate research school BIOTECH-
PHARMA
2008 Founding of the Bonn International Graduate School - BIGS-Biotech-Pharma
– in 2009 renamed as BIGS-Drug Sciences (BIGS-DrugS) – and member of
the BIGS advisory board of the University of Bonn
2008 Submitter in charge/speaker of the BMBF-BioPharma Project Neuroalliance
(“Innovative Therapeutika und Diagnostika für neurodegenerative Erkran-
kungen”) (together with A. Pfeifer); Funding: initially 20 Mio. e for 3 years

Memberships in scientific organisations (selection)

German Pharmaceutical Society (DPhG)
Society of German Chemists (GdCh)
American Chemical Society (ACS)
International Society for Heterocyclic Chemistry (ISHC)
Activities as a science reviewer (selection)
• i.a. for DFG, EU, Swiss, Australian, Finnish, Irish, Hongkong Research Councils,
German-Israeli Science Foundation, NATO, Humboldt Foundation, Deutsche Krebshilfe
• for numerous scientific journals in the areas of chemistry, pharmacy, pharmacology, biochemistry;
very frequently for J. Med. Chem.

Editorial activities and organisation of conferences (selection)

• i.a. Member of the editorial boards of Pharmacology & Therapeutics, Mini-Reviews in Medicinal
Chemistry, Expert Opinion on Therapeutic Patents, Purinergic Signalling
• Organisation of various national symposia and conferences
• member in the Scientific Advisory Boards of various international conferences (e.g. Purines 2008 in
Copenhagen, Denmark; logP 2009 ETH Zürich, Switzerland; Purine Club Meeting 2009, Camerino,
Italy).

Scholarships, vocations, awards (selection)

1989-1992 DFG postdoctoral fellowship
1992 Scholarship of the National Cancer Institute, NIH, USA
1995 Scientific award for the promotion of research by the Industrie- und Handels-
kammer Würzburg-Schweinsfurt
2004-2008 Member of the NATO Science Committee CBP (Chemistry/Biology/Physics)
Advisory Panel (“Science for Peace”)
2005 Invitation to become a member of the editorial board of
“Purinergic Signalling” by the chief editor, Prof. Dr. Geoffrey Burnstock
2005 Appointment as a member of the Scientific Advisory Board Neuro-Research of
the Research Center Jülich (for 5 years)
2007 Appointment as a member of the Scientific Committee of the Research Associa-
tion of Pharmaceutical Producers (FAH)
2008 Appointment as a member of the selection committee of the
Alexander-von-Humboldt Foundation